"Anti-Inflammatory Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that reduce or suppress INFLAMMATION.
| Descriptor ID |
D000893
|
| MeSH Number(s) |
D27.505.954.158
|
| Concept/Terms |
Anti-Inflammatory Agents- Anti-Inflammatory Agents
- Anti Inflammatory Agents
- Agents, Antiinflammatory
- Antiinflammatories
- Antiinflammatory Agents
- Agents, Anti-Inflammatory
- Agents, Anti Inflammatory
- Anti-Inflammatories
- Anti Inflammatories
|
Below are MeSH descriptors whose meaning is more general than "Anti-Inflammatory Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Inflammatory Agents".
This graph shows the total number of publications written about "Anti-Inflammatory Agents" by people in this website by year, and whether "Anti-Inflammatory Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 5 | 7 |
| 1997 | 4 | 3 | 7 |
| 1998 | 2 | 5 | 7 |
| 1999 | 4 | 3 | 7 |
| 2000 | 2 | 4 | 6 |
| 2001 | 3 | 6 | 9 |
| 2002 | 2 | 3 | 5 |
| 2003 | 6 | 4 | 10 |
| 2004 | 5 | 5 | 10 |
| 2005 | 6 | 6 | 12 |
| 2006 | 7 | 7 | 14 |
| 2007 | 9 | 2 | 11 |
| 2008 | 9 | 12 | 21 |
| 2009 | 8 | 6 | 14 |
| 2010 | 5 | 3 | 8 |
| 2011 | 15 | 12 | 27 |
| 2012 | 4 | 5 | 9 |
| 2013 | 7 | 7 | 14 |
| 2014 | 10 | 10 | 20 |
| 2015 | 11 | 4 | 15 |
| 2016 | 6 | 8 | 14 |
| 2017 | 8 | 8 | 16 |
| 2018 | 6 | 1 | 7 |
| 2019 | 6 | 4 | 10 |
| 2020 | 7 | 7 | 14 |
| 2021 | 6 | 6 | 12 |
| 2022 | 1 | 1 | 2 |
| 2023 | 1 | 6 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Inflammatory Agents" by people in Profiles.
-
Unlocking the miRNA-34a-5p/TGF-? and HMGB1/PI3K/Akt/mTOR crosstalk participate in the enhanced cardiac protection of liraglutide against isoproterenol-induced acute myocardial injury rat model. Int Immunopharmacol. 2024 Jan 25; 127:111369.
-
Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study. Lung. 2023 12; 201(6):617-624.
-
Macrophage angiotensin AT2 receptor activation is protective against early phases of LPS-induced acute kidney injury. Am J Physiol Renal Physiol. 2023 11 01; 325(5):F552-F563.
-
Novel Anti-Inflammatory Approaches to COPD. Int J Chron Obstruct Pulmon Dis. 2023; 18:1333-1352.
-
Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening. Future Med Chem. 2023 05; 15(9):757-767.
-
The anti-inflammatory effects of aerobic exercise training in patients with type 2 diabetes: A systematic review and meta-analysis. Cytokine. 2023 04; 164:156157.
-
Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review. J Ocul Pharmacol Ther. 2023 03; 39(2):89-101.
-
A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort. PLoS One. 2023; 18(1):e0280079.
-
Recombinant Thrombomodulin Has Anti-tumor Effects and Enhances the Effects of Gemcitabine for Pancreatic Cancer Through G-protein Coupled Receptor 15. Anticancer Res. 2022 Oct; 42(10):4679-4687.
-
The clock modulator Nobiletin mitigates astrogliosis-associated neuroinflammation and disease hallmarks in an Alzheimer's disease model. FASEB J. 2022 03; 36(3):e22186.